Professor Danny McAuley from the Centre for Infection and Immunity, a partner in developing the new nanomedicine, said that, if successful, this nanomedicine could also have application in other common lung disorders such as Chronic Obstructive Pulmonary Disease (COPD) and Cystic Fibrosis.
The University of Colorado researchers are studying molecular mechanisms of normal acclimatization in healthy people to gain new treatment ideas for people with chronic obstructive pulmonary disease, or COPD, a common lung disease.